Public Board of Directors papers 260123

As shown in the table there are no significant variances from the planned financial performance against key measures. Measure of Financial Performance Red / Amber / Green rating Revenue: Trust Control Total compared to breakeven plan £75k Capital: Capital expenditure against plan 20.1% below plan CIP achieved (recurrent) against target £4m of £7.3m target Debtor days compared to 15-day target 10 days Cash balance £146,303k Financial details are provided in the Integrated Performance, Quality and Finance Report Responsible Executive Director – Finance Director Responsible Assurance Committee – Audit Operational Performance Overall performance remains strong apart from the 62-day referral to treatment standard. The December 62-day position has deteriorated slightly from November to 78.5% compliance (subject to validation). We have continued to achieve the 31-day standard for treatment to start within 31 days of the decision to treat. Activity levels are monitored against agreed 2022/23 plan. At month 9, chemotherapy deliveries and radiotherapy fractions along with non-elective spells continue to be above plan whilst all other points of delivery are either on plan or tracking slightly below plan. No operations were cancelled on the day for non-clinical reasons. Performance details are in the Integrated Performance, Quality and Finance Report The reported metrics confirm that the quality of care at The Christie continues to be outstanding despite the pressures of recent years. This is confirmed in the most recent CQC Insights Report (June 2022). Safer staffing numbers have met the required acuity levels to ensure appropriate levels of safety and care for our patients. Indicative staffing, in line with nursing establishments, is set to maintain a 1:6 nurse to patient ratio. On occasion this has been extended to 1:8 which is in line with recommended national staffing ratios. While we have seen an increase in patient safety incidents, following thematic review, these were not related to nurse staffing ratios. We continue to report cases of a range of infections although other than for C Difficile there are no national standards or thresholds. Although we continue to have patients with C Difficile, reflecting community prevalence of infection and the vulnerability of our patients, audits show that in no case has infection been the result of a lapse in the standards of care. There were no cases of hospital acquired nosocomial COVID-19 infections in December. The number of formal complaints reduced slightly in December compared to the monthly average, the number of contacts with the Patient Advice and Liaison Service (PALS) service decreased from 42 in November to 38 in December. Responsible Executive Director – Chief Operating Officer Responsible Assurance Committee – Quality Assurance Quality of Care

21